siRNA, Anti-MAP2K2, 2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT18613WQ-2MOE)

The product SIRGT18613WQ-2MOE is a type of small interfering RNA (siRNA) that targets MAP2K2 gene and regulates the expression of gene. The siRNA interferes with the expression of MAP2K2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_030662.3
Alternative Names CFC4; MAPKK2; MEK2; MKK2; PRKMK2
Related Diseases Cardiofaciocutaneous Syndrome
Purification HPLC
Target Gene
Gene ID 5605
Uniprot ID P36507
Sub Cat Target Species Modification Scale  
SIRGT19613WQ-LNA MAP2K2 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT16613WQ-RB MAP2K2 Human Ribo-modified Inquiry
SIRGT17613WQ-BB MAP2K2 Human Backbone-modified Inquiry

Related Products